VKTX Insider Trading

Viking Therapeutics, Inc. (VKTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.73B, listed on NASDAQ, employing roughly 65 people, carrying a beta of 0.65 to the broader market. Viking Therapeutics, Inc. Led by Brian Lian, public since 2015-04-28.

In the last 12 months, Viking Therapeutics, Inc. insiders made 1 buy transaction and 16 sale transactions.

DateNameTypeSharesPriceValue
Aug 7, 2026Kelly-Gemmell Dorothy ElizabethA-Award40,800$31.74$1.3M
Aug 7, 2026Kelly-Gemmell Dorothy ElizabethA-Award6,333$0.00$0
Aug 7, 2026Kelly-Gemmell Dorothy Elizabeth0$0.00$0
Jul 29, 2026Lian BrianA-Award221,667$0.00$0
Jul 29, 2026Lian BrianS-Sale148,517$33.32$4.9M
Jul 29, 2026ZANTE GREGA-Award31,667$0.00$0
Jul 29, 2026ZANTE GREGS-Sale21,217$33.47$710.1K
Jul 29, 2026Mancini MariannaA-Award31,667$0.00$0
Jul 29, 2026Mancini MariannaS-Sale18,217$33.47$609.6K
Jun 3, 2026Chen Hubert CA-Award190,000$31.27$5.9M

VKTX Insider Activity by Quarter

Reported Form 4 and Form 5 lines under VKTX's own SEC company ID, by transaction date, back to Q4 2024. Purchases and sales are code P / S (open market or private) in the company's shares; other lines are purchases and sales of other securities (options, warrants, preferred), awards, exercises, tax withholding, gifts and other acquisitions and dispositions. Later filings and amendments can change the current quarter. Earlier quarters are not shown: the filings read reach back to Jan 23, 2018, and a quarter counts only when every filing for it was read. Last refreshed Oct 28, 2026.

QuarterPurchasesBoughtSalesSoldOther Lines
Q4 2026 (so far)0N/A0N/A0
Q3 20260N/A3$6.3M5
Q2 20260N/A0N/A1
Q1 20261$149.9K13$12.1M22
Q4 20250N/A4$3.9M9
Q3 20250N/A3$984.5K3
Q2 20250N/A0N/A2
Q1 20251$29.9K6$12.8M14
Q4 20240N/A11$12.4M14

VKTX Institutional Ownership (13F)

As of Jun 30, 2026 (Q2 2026), 434 institutions reported holding 75,765,272 VKTX shares, valued at $2.96B as reported, 67.2% of its market cap (market cap of Jun 26, 2026). That is +20 institutions from the quarter before. Among managers whose reports for both quarters are comparable, 66 opened a position, 44 closed one, 143 added and 131 trimmed.

Top Holders, Q2 2026

ManagerSharesValueChange
FMR LLC6,335,756$247.2M+311,003
BlackRock, Inc.6,189,649$241.5M-690,641
STATE STREET CORP5,606,394$218.7M+1,210,837
VANGUARD CAPITAL MANAGEMENT LLC5,053,663$197.1M+41,161
VANGUARD PORTFOLIO MANAGEMENT LLC4,484,263$174.9M+19,965
TWO SIGMA INVESTMENTS, LP3,937,414$153.6M-494,728
MORGAN STANLEY3,486,040$136.0M+472,112
AMERIPRISE FINANCIAL INC2,156,083$84.1M+477,338
GEODE CAPITAL MANAGEMENT, LLC2,097,981$81.9M+15,914
AMERICAN CENTURY COMPANIES INC1,816,050$70.8M-262,527

By Quarter

QuarterInstitutionsSharesValue
Q2 202643475,765,272$2.96B
Q1 202641473,322,848$2.43B
Q4 202542672,066,464$2.54B
Q3 202537073,846,274$1.94B
Q2 202539176,856,110$2.04B
Q1 202536976,550,994$1.85B
Q4 202440782,020,224$3.30B
Q3 202441984,772,461$5.32B
Q2 202438683,696,077$4.44B

From the SEC's Form 13F data sets: investment managers with $100 million or more in Section 13(f) securities report their holdings each quarter, up to 45 days after it ends; a restated filing replaces the original, and values are as the managers reported them (a position whose price runs about 1,000 times below other managers', from a manager whose positions mostly do, is read as reported in thousands of dollars). The same shares can be reported by more than one manager, so totals can count some twice.

ETFs Holding VKTX

FundWeight of VKTXShares (as reported)Value (as reported)Source updated
VTI Vanguard Morningstar Total Stock Market ETF0.01%3,754,047$122.4MNov 12, 2026
XBI State Street SPDR S&P Biotech ETF0.96%3,637,660$103.5MNov 12, 2026
VB Vanguard Morningstar Small-Cap ETF0.05%2,660,624$86.7MNov 12, 2026
VBK Vanguard Morningstar Small-Cap Growth ETF0.11%1,482,827$48.3MNov 12, 2026
VXF Vanguard Extended Market ETF0.05%1,403,478$45.8MNov 12, 2026
SCHA Schwab U.S. Small-Cap ETF0.08%664,673$18.3MNov 13, 2026
IWR iShares Russell Mid-Cap ETF0.02%516,583$14.7MNov 12, 2026
VHT Vanguard Health Care ETF0.05%337,006$11.0MNov 12, 2026
IWD iShares Russell 1000 Value ETF0.01%247,944$7.1MNov 12, 2026
ITOT iShares Core S&P Total U.S. Stock Market ETF0.00%160,199$4.6MNov 12, 2026
IWS iShares Russell Mid-Cap Value ETF0.03%160,050$4.6MNov 12, 2026
LABU Direxion Daily S&P Biotech Bull 3X Shares0.19%131,523$3.7MNov 13, 2026
VT Vanguard Total World Stock ETF0.00%104,697$3.4MNov 12, 2026
OZEM Roundhill Investments - GLP-1 & Weight Loss ETF4.56%94,629$2.6MNov 13, 2026
IYH iShares U.S. Healthcare ETF0.05%83,150$2.4MNov 12, 2026

From each fund's latest holdings file on record that shows VKTX's listed security itself. A file counts when its line count is consistent with the fund's reported holdings count (at most twice it plus 10, or at most 1,000 lines for a reported count of exactly 10, which the data source gives many funds as a cap), read with that file or inherited from the fund's last classified file (within 20% of its line count, read within 60 days). Funds whose line for the company could not be confirmed as VKTX's listed security, or that hold it through underlying funds (look-through), are not listed. Only long positions count: a fund is left out when any of its lines for VKTX reports a negative weight, share count or value, or none of them above zero (a short position, or figures that disagree). Shares, value and weight are as reported in each fund's file, dated by the data source's last update of that file (not the date of the positions); the weight is VKTX's share of that fund.

How to Read VKTX Insider Activity

Net insider sentiment skews to the sell side over the trailing twelve months: 16 sales versus 1 buys. Insider sales carry less informational weight than buys because they are often driven by liquidity, tax planning, or pre-scheduled Rule 10b5-1 trading plans rather than negative information. The transaction type alone does not say whether a sale was made on the open market or privately, or under a 10b5-1 plan; the filing's plan checkbox and footnotes do. The transaction table above includes the filer's reporting name, transaction type, share count, per-share price, and total dollar value where computable. For options traders, insider activity is one input to event-driven sizing alongside earnings calendar, analyst-rating cluster moves, and the implied-vol surface. Form 4 filings (the dominant Section 16 reporting form) must be submitted within two business days of the transaction; clusters of buys across multiple insiders within a short window are the strongest informational pattern. SEC EDGAR carries the underlying source filings for verification and additional historical depth.

Learn how insider trading is reported and how to read the data →

Frequently asked VKTX insider trading questions

How active are VKTX insiders right now?
Over the trailing twelve months, Viking Therapeutics, Inc. (VKTX) insiders made 1 buy transaction and 16 sale transactions. Net insider sentiment over the trailing twelve months tilts to the sell side (16 sales vs 1 buys). The transaction list above shows the most recent filings; each entry includes the insider's name, transaction type, share count, and per-share price.
What counts as an insider transaction?
Section 16 of the Securities Exchange Act requires officers, directors, and 10% beneficial-owner shareholders to disclose changes in their holdings via Form 3 (initial statement), Form 4 (subsequent transactions, filed within two business days), and Form 5 (annual catch-up). Insider transactions cover open-market purchases and sales, exercise of stock options, gifts, and grants. The "transaction type" field on each row distinguishes these subcategories.
Are VKTX insider buys a bullish signal?
Insider purchases (Type P, made on the open market or privately; the code covers both) carry more informational weight than insider sales: an insider must commit personal capital, and the SEC scrutinizes purchases under Rule 10b5-1 for material non-public information. Sales, by contrast, are often driven by liquidity, tax planning, or pre-scheduled 10b5-1 trading plans rather than negative information. Cluster buying (multiple insiders buying within a short window) is a stronger signal than isolated buys.
How do VKTX insider transactions affect options pricing?
Insider transaction data does not directly drive implied volatility, but Form 4 disclosures can move single-name IV if the size or timing is unusual (e.g. a large CEO buy ahead of an earnings window). Options markets price the marginal informational content; routine transactions under pre-scheduled plans are typically ignored. For event-driven options sizing, pair the insider transaction history with the upcoming earnings calendar.